Chemic Laboratories Inc and Archimica Group Announce Joint Cooperation Agreement

August 24, 2009

Chemic Laboratories Inc. and Archimica Group today announced a joint cooperation agreement that will enable the two pharmaceutical development and manufacturing firms to cooperate on a variety of client engagements, primarily in the areas of Active Pharmaceutical Ingredient (API) research, development and production. Under this agreement, the companies can now leverage their collective expertise in pharmaceutical analytics, development and commercial manufacturing to make a definitive difference in their client's business performance speeding the time products can be brought to market.

"Chemic is very pleased to establish this formal working relationship with Archimica Group, which has a strong reputation as a global leader in the area of pharmaceutical API commercialization", said Joseph St. Laurent, President and CSO of Chemic Laboratories Inc. This joint agreement places our two firms at the forefront of the rapidly expanding marketplace of companies that are seeking to further outsource their pharmaceutical API development and commercial manufacturing activities.

Andreas Meudt, Managing Director of New Business Development for Archimica Group, commented that "The cooperation with Chemic Laboratories is another step in the strategy of Archimica to support its customers with rapid commercialization services in the areas of innovative API, DEA controlled drugs and high-tech building blocks". Via this cooperation, Archimica is further pursuing its focus on high-value products with significant differentiation on the technological and on the regulatory side and further expands the Archimica offering for DEA regulated materials.

The cooperation model between the two companies will consist in Archimica quickly scaling DEA controlled and other API to commercial scale after Chemic Laboratories have developed and produced the first quantities, resulting in very fast and reliable supply of customers with highest quality API. Together with the existing DEA controlled drug portfolio and several new controlled APIs under development, this is another step forward in broadening the company portfolio.

About Chemic Laboratories, Inc.:
Your Partner for a Successful Future©

Chemic Laboratories is a privately held full service FDA registered and DEA licensed, cGMP/ GLP Contract Chemistry Organization (CCO) founded in 1998. Chemic offers unparalleled contract Analytical, API Synthesis, and Formulation Development, to the Pharmaceutical, Biotech, and Medical Device industries. Chemic Laboratories offers these services by providing a strategically designed, highly technical facility, equipped with state of the art instrumentation. All programs can be conducted under the strict auspices of FDA and EMEA guidelines.

About Archimica:
Strong. Steady. Focused on Pharmaceuticals.

Archimica is a privately held leading pharmaceutical fine chemicals company that combines world-scale chemical manufacturing experience with a history of pharmaceutical commercialization that stretches back over 40 years. Archimica is particularly focused on the custom synthesis of innovative building blocks, intermediates and APIs in close cooperation with its clients. The company has more than 600 employees at seven production sites in Italy, France, Germany, US and UK and sales of € 112 million in 2008.


Membership Deliverables

MassBio Membership gives you:

Purchasing power-MassBio negotiates a broad-based collection of services on behalf of member companies and passes the savings on to its members. 

Networking and professional development-MassBio organizes and executes numerous conferences, committee meetings, and networking events throughout the year.

MassBio Signature Events-Attend our Investors Forum, Innovator Roundtables, Pharma Days, our Golf Classic Fundraiser, Policy Leadership Breakfast, and many others.

Public policy & Advocacy-As the state's leading advocate for our life science super cluster, we fight for public policy initiatives and tax incentives in Massachusetts and Washington, D.C., that will enable biotechnology companies to do their best work.

Economic development-MassBio provides expert advice and guidance to help companies find suitable locations and resources as they move to and grow in the Bay State. We make Massachusetts a better place for your business.

Visibility/Resources-Members are listed on a searchable directory that includes a profile and link to the company's website. We highlight your company's latest news by posting to our MassBio member news page. In addition, members can post job openings on our website free!

Educational incentives-We promote education, workforce development and lifelong learning through the MassBioEd Foundation. The foundation customizes training programs for companies and educational institutions and promotes science in the classroom through BioTeach. MassBio members receive a discount on courses offered by the foundation.